Rebecca Kruse-Jarres

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Helicobacter Pylori

Pulmonary Embolism

Combination Therapy

Decision Making

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jacqueline N Poston, Rebecca Kruse-Jarres
How I treat von Willebrand disorders in the elderly. Blood (2023)
Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y Doral, Stacy E Croteau, Thierry Lambert, Christine L Kempton, Steven W Pipe, Richard H Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Aaron Young, Victor Jimenez Yuste
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies. Blood advances (2022)
Melody Benton, Anisha M Patel, Lizheng Shi, Alisha M Monnette, Dongzhe Hong, Rebecca Kruse-Jarres, Karina Raimundo
Assessing patient and caregiver preferences for treatment of haemophilia A: A discrete choice experiment. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2020)
Rebecca Kruse-Jarres, Johannes Oldenburg, Elena Santagostino, Midori Shima, Christine L Kempton, Craig M Kessler, Michaela Lehle, Sammy Chebon, Nives Selak Bienz, Elina Asikanius, Johnny N Mahlangu
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Elena Santagostino, Maggie Moore, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Rebecca Kruse-Jarres, Jill M Johnsen
How I treat type 2B von Willebrand disease. Blood 131 (12) (2018)
Johannes Oldenburg, Johnny N Mahlangu, Willem Bujan, Peter Trask, Michael U Callaghan, Guy Aaron Young, Elina Asikanius, Flora Peyvandi, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler, Jin Xu, Jerzy Windyga, Midori Shima, Sylvia von Mackensen
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)
Rebecca Kruse-Jarres, Christine L Kempton, Francesco Baudo, Peter W Collins, Paul Knoebl, Cindy A Leissinger, Andreas Tiede, Craig M Kessler
Acquired hemophilia A: Updated review of evidence and treatment guidance. American journal of hematology 92 (7) (2017)